Author: Richard, A; Tulasne, D
Title: Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis Document date: 2012_3_8
ID: 3hxau5vt_10
Snippet: Kaposi sarcoma-associated herpesvirus (KSHV) establishes long-term infections leading to Kaposi sarcomas and can go through either latent or lytic cycle. When KSHV is reactivated, ORF57 (or Mta or KS-SM) is detected by western blot as a doublet, 30 with the smaller product being abolished by a pan caspase inhibitor. In vitro, caspase 7, which is activated on KSHV reactivation, and to a lesser extent caspases 5 and 10, are able to process ORF57 at.....
Document: Kaposi sarcoma-associated herpesvirus (KSHV) establishes long-term infections leading to Kaposi sarcomas and can go through either latent or lytic cycle. When KSHV is reactivated, ORF57 (or Mta or KS-SM) is detected by western blot as a doublet, 30 with the smaller product being abolished by a pan caspase inhibitor. In vitro, caspase 7, which is activated on KSHV reactivation, and to a lesser extent caspases 5 and 10, are able to process ORF57 at 30 DETD 33 k. Interestingly, coexpression assays show that ORF57 cleavage product (i.e. ORF57 lacking residues 1-33) is no longer able to promote viral lytic gene expression. Accordingly, complementing a stable cell line containing an orf57-null KSHV genome with ectopic WT or uncleavable ORF57 promotes lytic gene expression, while ORF57 lacking residues 1-33 does not. Consistently, the number of cell-free virus particles dramatically increases when caspase 7 is inhibited. Thus, ORF57 cleavage would prevent proper expression of its downstream targets and subsequent full reactivation of KSHV, suggesting that it allows KSHV to maintain a persistent infection.
Search related documents:
Co phrase search for related documents- cell free virus and gene expression: 1
- cell line and cleavage product: 1
- cell line and downstream target: 1, 2, 3
- cell line and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- cell line and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- cell line and lytic gene expression: 1
- cell line and lytic latent: 1
- cell line and pan caspase: 1, 2
- cell line and pan caspase inhibitor: 1, 2
- cell line and persistent infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cell line and persistent infection maintain: 1
- cell line and western blot detect: 1, 2, 3, 4, 5
- cleavage product and gene expression: 1, 2, 3, 4
- cleavage product and pan caspase: 1
- cleavage product and pan caspase inhibitor: 1
- cleavage product and persistent infection: 1
- cleavage product and persistent infection maintain: 1
- cleavage product and small product: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date